Lv4
418 积分 2025-03-28 加入
Leading AI-Driven Drug Discovery Platforms: 2025 Landscape and Global Outlook
2天前
已完结
Advancing Parkinson’s disease treatment: cell replacement therapy with neurons derived from pluripotent stem cells
2个月前
已完结
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model
2个月前
已完结
Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design
2个月前
已完结
The coming of age of cyclic peptide drugs: an update on discovery technologies
2个月前
已完结
Cyclic Peptide Therapeutic Agents Discovery: Computational and Artificial Intelligence-Driven Strategies
2个月前
已完结
Evaluation of proximod, a selective agonist of sphingosine-1-phosphate receptor-1, in healthy volunteers and patients with rheumatoid arthritis: a phase 1, double-blind, randomised, placebo-controlled, ascending dose trial
3个月前
已完结
GLP-1 receptor agonists
3个月前
已完结
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update
3个月前
已完结
The evolving landscape of obesity pharmacotherapy
3个月前
已完结
皖公网安备34019202002308
